Cusano Francesco, Sampogna Francesca, Brunasso Vernetti Alexandra Maria Giovanna, Stisi Stefano, Sandri Gilda, Malara Giovanna, Naldi Luigi, Pellegrino Michele, Tripepi Giovanni Luigi, di Luzio Paparatti Umberto, Agnusdei Concetto Paolo, Bonifati Claudio, Celano Antonella, Corazza Valeria, D'Agostino Federica, De Pasquale Rocco, Filippucci Emilio, Foti Rosario, Galdo Giovanna, Gai Fabiana, Ganzetti Giulia, Graceffa Dario, Maccarone Mara, Mazzotta Annamaria, Melchionda Gennaro, Molinaro Francesca, Paoletti Franco, Tonolo Silvia, Vercellone Adriano, Vitetta Rosetta, Massone Cesare, Sebastiani Gian Domenico
Dermatology Unit, "G. Rummo" Hospital, Benevento; ADOI President.
Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata-IRCCS, Rome.
Dermatol Reports. 2022 Sep 26;14(3):9541. doi: 10.4081/dr.2022.9541. eCollection 2022 Sep 14.
Psoriasis is a complex disease often needing a multidisciplinary approach. In particular, the collaboration between dermatologist and rheumatologist is crucial for the management of patients suffering from both psoriasis (PSO) and psoriatic arthritis (PsA). Here we report a series of recommendations from a group of experts, as a result of a Consensus Conference, defining the circumstances in which it is preferable or even mandatory, depending on the available settings, to rely on the opinion of the two specialists, jointly or in a deferred manner. Indications are given on how to organize a 3 level joint Dermatology- Rheumatology care unit, in connection with 1 and 2 level clinicians of both specialties, GPs, and other specialists involved in the management of psoriasis. A potential patient journey is suggested, that can be used as a basis for future design and validation of national and/or local diagnostic therapeutic and assistance pathways.
银屑病是一种复杂的疾病，通常需要多学科方法。特别是，皮肤科医生和风湿病学家之间的合作对于同时患有银屑病（PSO）和银屑病关节炎（PsA）的患者的管理至关重要。在此，我们报告一组专家在共识会议后提出的一系列建议，这些建议根据现有情况，确定了在何种情况下联合或延期依赖两位专家的意见更为可取甚至是必要的。文中给出了关于如何与两个专科的1级和2级临床医生、全科医生以及参与银屑病管理的其他专家合作，组建一个三级皮肤科 - 风湿病联合护理单元的指导意见。还提出了一个潜在的患者就医流程，可作为未来设计和验证国家和/或地方诊断治疗及援助路径的基础。
